title: [Surveillance of patients with Barrett's esophagus].
abstract: Barret's esophagus (BE) is defined as a situation in which the distal esophageal squamous epithelium was replaced by columnar epithelium, with or without goblet cells. BE is considered a significant risk factor for the development of esophageal cancer, however, screening is recommended only for high risk patients. The new guidelines determine the proper terminology of the endoscopic appearance of BE and the way that biopsies should be taken. After BE is confirmed, surveillance is extremely important as its performance has been shown to prevent cancer and death. The surveillance is based on the endoscopic and pathological findings, highlighting the importance of advanced endoscopy and specialized pathology expertise. The guidelines determine the place of the endoscopic ablative technology and specialized surgery in these patients.
authors.affiliation: The Section of Gastrointestinal Oncology, Israeli Gastroenterology Association.
authors.forename: Zohar
authors.initials: Z
authors.lastname: Levi
authors.forename: Alex
authors.initials: A
authors.lastname: Vilkin
authors.forename: Menachem
authors.initials: M
authors.lastname: Moshkowitz
authors.forename: Revital
authors.initials: R
authors.lastname: Kariv
authors.forename: Betsi
authors.initials: B
authors.lastname: Half
authors.forename: Yaron
authors.initials: Y
authors.lastname: Niv
mesh_terms: D001471:Barrett Esophagus / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D001706:Biopsy; D004938:Esophageal Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D004945:Esophagoscopy / Q000379:methods*; D006801:Humans; D008403:Mass Screening / Q000379:methods; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D009626:Terminology as Topic